A systematic investigation on the presence of Ps. aeruginosa in the nasopharynx, throat, feces, and on the skin of 143 premature infants was carried out and the following observations were made. 1.Ps. aeruginosa was isolated from the skin in 25 per cent of these patients, from the feces in 51 per cent, from the nasopharynx in 27 per cent, and from the throat in 40 per cent. 2.Ps. aeruginosa was found in only one individual on the day of admission in the feces, though not in the throat, nasopharynx, or on the skin; from 16 per cent to 47 per cent (depending upon the specimen) of the infants harbored this microorganism on the third or fourth day after admission, indicating that this microorganism was acquired readily within a few days after admission to the nursery. 3.Of thirty-five premature infants more than half carried this microorganism in the feces and throat for two weeks; the carrier state of the skin tended to be more transient. 4.Ps. aeruginosa was present in large numbers on the skin of 6 per cent of the infants, in the feces in 17 per cent, in the nasopharynx in 16 per cent, and in the throat in 21 per cent. 5.In the majority of these premature infants the presence of this microorganism was not associated with clinical infection. Systemic infection, however, occurred in five patients, four of whom died. A brief résumé of these cases is presented. 6.ACTH was administered to twenty infants for the treatment of retrolental fibroplasia, sixteen of whom also received antibiotics. Systemic infection with Ps. aeruginosa followed ACTH therapy in three instances. 7.The “outbreak” of the Ps. aeruginosa carrier state terminated without special measures, and this microorganism has been encountered in premature infants during the ensuing two years only occasionally. 8.The significance of these findings, with particular reference to the Ps. aeruginosa carrier state and the potential pathogenicity of this bacterial species, is discussed. A systematic investigation on the presence of Ps. aeruginosa in the nasopharynx, throat, feces, and on the skin of 143 premature infants was carried out and the following observations were made. 1.Ps. aeruginosa was isolated from the skin in 25 per cent of these patients, from the feces in 51 per cent, from the nasopharynx in 27 per cent, and from the throat in 40 per cent. 2.Ps. aeruginosa was found in only one individual on the day of admission in the feces, though not in the throat, nasopharynx, or on the skin; from 16 per cent to 47 per cent (depending upon the specimen) of the infants harbored this microorganism on the third or fourth day after admission, indicating that this microorganism was acquired readily within a few days after admission to the nursery. 3.Of thirty-five premature infants more than half carried this microorganism in the feces and throat for two weeks; the carrier state of the skin tended to be more transient. 4.Ps. aeruginosa was present in large numbers on the skin of 6 per cent of the infants, in the feces in 17 per cent, in the nasopharynx in 16 per cent, and in the throat in 21 per cent. 5.In the majority of these premature infants the presence of this microorganism was not associated with clinical infection. Systemic infection, however, occurred in five patients, four of whom died. A brief résumé of these cases is presented. 6.ACTH was administered to twenty infants for the treatment of retrolental fibroplasia, sixteen of whom also received antibiotics. Systemic infection with Ps. aeruginosa followed ACTH therapy in three instances. 7.The “outbreak” of the Ps. aeruginosa carrier state terminated without special measures, and this microorganism has been encountered in premature infants during the ensuing two years only occasionally. 8.The significance of these findings, with particular reference to the Ps. aeruginosa carrier state and the potential pathogenicity of this bacterial species, is discussed.
Read full abstract